Compound-42 alleviates acute kidney injury by targeting RIPK3-mediated necroptosis.
He XY, Wang F, Suo XG, Gu MZ, Wang JN, Xu CH, Dong YH, He Y, Zhang Y, Ji ML, Chen Y, Zhang MM, Fan YG, Wen JG, Jin J, Wang J, Li J, Zhuang CL, Liu MM, Meng XM.
He XY, et al. Among authors: he y.
Br J Pharmacol. 2023 Oct;180(20):2641-2660. doi: 10.1111/bph.16152. Epub 2023 Jul 1.
Br J Pharmacol. 2023.
PMID: 37248964
Free article.